2025
International perspective on social cognition in schizophrenia: current stage and the next steps
Corbera S, Kurtz M, Achim A, Agostoni G, Amado I, Assaf M, Barlati S, Bechi M, Cavallaro R, Ikezawa S, Okano H, Okubo R, Penadés R, Uchino T, Vita A, Yamada Y, Bell M. International perspective on social cognition in schizophrenia: current stage and the next steps. European Psychiatry 2025, 68: e9. PMID: 39812093, PMCID: PMC11795453, DOI: 10.1192/j.eurpsy.2024.1776.Peer-Reviewed Original ResearchConceptsSocial cognitionSocial neuroscienceAssess social cognitionSocial cognitive measuresSocial cognitive abilitiesClinical psychologyCognitive measuresSocial dysfunctionCognitive abilitiesSchizophreniaCognitive evaluationFunctional difficultiesCognitionCognitive scienceClinical practiceNeuroscienceMounting evidenceInternational scientific researchPsychologyCliniciansPsychiatryPoor clinical outcomesScientific rigorIllnessResearch
2024
Cognitive training for schizophrenia: Do race and ethnicity matter?
Gu B, Rose J, Kurtz M. Cognitive training for schizophrenia: Do race and ethnicity matter? Schizophrenia Research 2024, 272: 20-25. PMID: 39181007, PMCID: PMC11848525, DOI: 10.1016/j.schres.2024.08.009.Peer-Reviewed Original ResearchCognitive remediation treatmentCognitive trainingResponse to cognitive trainingEvidence-based psychosocial treatmentsTreatment drop-out ratesLevel of cognitive impairmentImpairment prior to treatmentRacial/ethnic minority statusCognitive remediationWorking memoryPsychosocial treatmentsCognitive deficitsDrop-out rateSymptom severityCognitive impairmentSchizophreniaSecondary analysis of dataRacial/ethnic minoritiesTreatment responseRacial/ethnic differencesMinority statusLevel of improvementCognitionMild to moderate improvementResearch literatureDo metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation.
Melville G, Hoffman M, Pollock A, Kurtz M. Do metacognitive therapies for schizophrenia-spectrum disorders work? A meta-analytic investigation. Psychological Medicine 2024, 54: 1510-1518. PMID: 38509837, DOI: 10.1017/s0033291724000564.Peer-Reviewed Original ResearchSchizophrenia spectrum disordersMetacognitive therapyNegative symptomsSocial cognitionEfficacy of metacognitive therapyMeta-cognitive therapySingle-session interventionSmall-to-moderate effectsDuration of illnessAntipsychotic dosagePositive symptom outcomesPositive symptomsIllness insightPotential moderatorsPsychosocial functioningSymptom outcomesCognitive biasesSecondary symptomsControlled trialsClinical insightsSample differencesCognitionSmall effectsSymptomsDisorders
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply